A surrogate ELISA to select high titer human convalescent plasma for treating immunocompromised patients infected with SARS-CoV-2 variants of concern.
Dolange V, Slamanig S, Abdeljawad A, Ying TL, Lemus N, Singh G, Carreño JM, Abad A, Srivastava K, Simon V, Sachithanandham J, Pekosz A, Sullivan D, Krammer F, Sun W, Palese P, González-Domínguez I.
Dolange V, et al. Among authors: ying tl.
J Infect Dis. 2025 Jan 3:jiae645. doi: 10.1093/infdis/jiae645. Online ahead of print.
J Infect Dis. 2025.
PMID: 39749487